"Dangerous to big pharma"...I feel We are being eyeballed at all times... for our tandem ability/potential to both damage revenue streams...and create revenue streams...a double-edged sword...hanging over the head of possible suitors. I count on...once again on corporate Avarice...and the very real existing FOMO...it's like musical chairs...someone is left standing.